K-to-M substitutions were shown to represent a mechanism to alter epigenetic states in a variety of pathologies through the inhibition of SET domain enzymes, a conclusion made after the identification of the this mutation in oncohistones linked to numerous cancer types [32–34]. Here, SET is linked to cancer.